Global API(Active Pharmaceutical Ingredient) Intermediate Market Research Report 2020

The global API(Active Pharmaceutical Ingredient) Intermediate market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.

This report focuses on API(Active Pharmaceutical Ingredient) Intermediate volume and value at the global level, regional level and company level. From a global perspective, this report represents overall API(Active Pharmaceutical Ingredient) Intermediate market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

    By Product

    By Type of Intermediate

    Oncology

    Diabetes

    Endocrinology

    Cardiovascular Disease

    CNS & Neurological Disorders

 Global API(Active Pharmaceutical Ingredient) Intermediate Market: Regional Analysis

The API(Active Pharmaceutical Ingredient) Intermediate market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the API(Active Pharmaceutical Ingredient) Intermediate market report are:

North America

    U.S.

    Canada

Europe

    Germany

    France

    U.K.

    Italy

    Russia

Asia-Pacific

    China

    Japan

    South Korea

    India

    Australia

    Taiwan

    Indonesia

    Thailand

    Malaysia

    Philippines

    Vietnam

Latin America

    Mexico

    Brazil

    Argentina

Middle East & Africa

    Turkey

    Saudi Arabia

    U.A.E

Global API(Active Pharmaceutical Ingredient) Intermediate Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global API(Active Pharmaceutical Ingredient) Intermediate market include:

    Jigs Chemical

    Sanofi Winthrop Industrie S.A.

    Shandong Jiulong Fine Chemical Co., Ltd.

    Hipharma Limited

    AMPAC Fine Chemicals

    BASF

    Cambrex Corporation

    A R Life Sciences Pvt. Ltd.

    Dragon Hwa ChemPharm. Co., Ltd.

    Ami Life Sciences Pvt. Ltd.

Table of Contents

1.1 Product Overview and Scope of API(Active Pharmaceutical Ingredient) Intermediate

1.2 API(Active Pharmaceutical Ingredient) Intermediate Segment By Product

1.2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate Comparison By Product (2021-2026)

1.3 API(Active Pharmaceutical Ingredient) Intermediate Segment by Application

1.3.1 API(Active Pharmaceutical Ingredient) Intermediate Sales Comparison by Application: 2020 VS 2026

1.3.2 Oncology

1.3.3 Diabetes

1.3.4 Endocrinology

1.3.5 Cardiovascular Disease

1.3.6 CNS & Neurological Disorders

1.4 Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Estimates and Forecasts

1.4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue 2015-2026

1.4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Sales 2015-2026

1.4.3 API(Active Pharmaceutical Ingredient) Intermediate Market Size by Region: 2020 Versus 2026

2.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Manufacturers (2015-2020)

2.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2015-2020)

2.3 Global API(Active Pharmaceutical Ingredient) Intermediate Average Price by Manufacturers (2015-2020)

2.4 Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Manufacturing Sites, Area Served, Product Type

2.5 API(Active Pharmaceutical Ingredient) Intermediate Market Competitive Situation and Trends

2.5.1 API(Active Pharmaceutical Ingredient) Intermediate Market Concentration Rate

2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue

2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

2.7 Primary Interviews with Key API(Active Pharmaceutical Ingredient) Intermediate Players (Opinion Leaders)

3.1 Global API(Active Pharmaceutical Ingredient) Intermediate Retrospective Market Scenario in Sales by Region: 2015-2020

3.2 Global API(Active Pharmaceutical Ingredient) Intermediate Retrospective Market Scenario in Revenue by Region: 2015-2020

3.3 North America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Country

3.3.1 North America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.3.2 North America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Country

3.4.1 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.4.2 Europe API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Region

3.5.1 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales by Region

3.5.2 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Country

3.6.1 Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.6.2 Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.6.3 Mexico

3.6.3 Brazil

3.6.3 Argentina

3.7 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Market Facts & Figures by Country

3.7.1 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.7.2 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 U.A.E

4.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type (2015-2020)

4.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Type (2015-2020)

4.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price Market Share by Type (2015-2020)

4.4 Global API(Active Pharmaceutical Ingredient) Intermediate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5.1 Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)

5.2 Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Application (2015-2020)

5.3 Global API(Active Pharmaceutical Ingredient) Intermediate Price by Application (2015-2020)

6.1 Jigs Chemical

6.1.1 Corporation Information

6.1.2 Jigs Chemical Description, Business Overview and Total Revenue

6.1.3 Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.1.4 Jigs Chemical Products Offered

6.1.5 Jigs Chemical Recent Development

6.2 Sanofi Winthrop Industrie S.A.

6.2.1 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.2.2 Sanofi Winthrop Industrie S.A. Description, Business Overview and Total Revenue

6.2.3 Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.2.4 Sanofi Winthrop Industrie S.A. Products Offered

6.2.5 Sanofi Winthrop Industrie S.A. Recent Development

6.3 Shandong Jiulong Fine Chemical Co., Ltd.

6.3.1 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.3.2 Shandong Jiulong Fine Chemical Co., Ltd. Description, Business Overview and Total Revenue

6.3.3 Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.3.4 Shandong Jiulong Fine Chemical Co., Ltd. Products Offered

6.3.5 Shandong Jiulong Fine Chemical Co., Ltd. Recent Development

6.4 Hipharma Limited

6.4.1 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.4.2 Hipharma Limited Description, Business Overview and Total Revenue

6.4.3 Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Hipharma Limited Products Offered

6.4.5 Hipharma Limited Recent Development

6.5 AMPAC Fine Chemicals

6.5.1 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.5.2 AMPAC Fine Chemicals Description, Business Overview and Total Revenue

6.5.3 AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.5.4 AMPAC Fine Chemicals Products Offered

6.5.5 AMPAC Fine Chemicals Recent Development

6.6 BASF

6.6.1 BASF API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.6.2 BASF Description, Business Overview and Total Revenue

6.6.3 BASF API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.6.4 BASF Products Offered

6.6.5 BASF Recent Development

6.7 Cambrex Corporation

6.6.1 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.6.2 Cambrex Corporation Description, Business Overview and Total Revenue

6.6.3 Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.4.4 Cambrex Corporation Products Offered

6.7.5 Cambrex Corporation Recent Development

6.8 A R Life Sciences Pvt. Ltd.

6.8.1 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.8.2 A R Life Sciences Pvt. Ltd. Description, Business Overview and Total Revenue

6.8.3 A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.8.4 A R Life Sciences Pvt. Ltd. Products Offered

6.8.5 A R Life Sciences Pvt. Ltd. Recent Development

6.9 Dragon Hwa ChemPharm. Co., Ltd.

6.9.1 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.9.2 Dragon Hwa ChemPharm. Co., Ltd. Description, Business Overview and Total Revenue

6.9.3 Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.9.4 Dragon Hwa ChemPharm. Co., Ltd. Products Offered

6.9.5 Dragon Hwa ChemPharm. Co., Ltd. Recent Development

6.10 Ami Life Sciences Pvt. Ltd.

6.10.1 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Production Sites and Area Served

6.10.2 Ami Life Sciences Pvt. Ltd. Description, Business Overview and Total Revenue

6.10.3 Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales, Revenue and Gross Margin (2015-2020)

6.10.4 Ami Life Sciences Pvt. Ltd. Products Offered

6.10.5 Ami Life Sciences Pvt. Ltd. Recent Development

7.1 API(Active Pharmaceutical Ingredient) Intermediate Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Raw Materials Price Trend

7.1.3 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

7.4 API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis

8.1 Marketing Channel

8.2 API(Active Pharmaceutical Ingredient) Intermediate Distributors List

8.3 API(Active Pharmaceutical Ingredient) Intermediate Customers

9.1 Market Trends

9.2 Opportunities and Drivers

9.3 Challenges

9.4 Porter's Five Forces Analysis

10.1 Global API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of API(Active Pharmaceutical Ingredient) Intermediate by Type (2021-2026)

10.1.2 Global Forecasted Revenue of API(Active Pharmaceutical Ingredient) Intermediate by Type (2021-2026)

10.2 API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of API(Active Pharmaceutical Ingredient) Intermediate by Application (2021-2026)

10.2.2 Global Forecasted Revenue of API(Active Pharmaceutical Ingredient) Intermediate by Application (2021-2026)

10.3 API(Active Pharmaceutical Ingredient) Intermediate Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of API(Active Pharmaceutical Ingredient) Intermediate by Region (2021-2026)

10.3.2 Global Forecasted Revenue of API(Active Pharmaceutical Ingredient) Intermediate by Region (2021-2026)

10.4 North America API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2021-2026)

10.5 Europe API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2021-2026)

10.6 Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2021-2026)

10.7 Latin America API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2021-2026)

10.8 Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Estimates and Projections (2021-2026)

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

List of Tables

    Table 1. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Growth Rate Comparison by Type (2015-2026)

    Table 2. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Comparison by Application: 2020 VS 2026

    Table 3. Global API(Active Pharmaceutical Ingredient) Intermediate Market Size by Type (K MT) (US$ Million) (2020 VS 2026)

    Table 4. Global Key API(Active Pharmaceutical Ingredient) Intermediate Manufacturers Covered in This Study

    Table 5. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Manufacturers (2015-2020)

    Table 6. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Manufacturers (2015-2020)

    Table 7. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million USD) by Manufacturers (2015-2020)

    Table 8. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers (2015-2020)

    Table 9. Global Market API(Active Pharmaceutical Ingredient) Intermediate Average Price (USD/MT) of Key Manufacturers (2015-2020)

    Table 10. Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Sales Sites and Area Served

    Table 11. Manufacturers API(Active Pharmaceutical Ingredient) Intermediate Product Types

    Table 12. Global API(Active Pharmaceutical Ingredient) Intermediate Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 13. Global API(Active Pharmaceutical Ingredient) Intermediate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in API(Active Pharmaceutical Ingredient) Intermediate as of 2019)

    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 15. Main Points Interviewed from Key API(Active Pharmaceutical Ingredient) Intermediate Players

    Table 16. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Region (2015-2020)

    Table 17. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region (2015-2020)

    Table 18. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) by Region (2015-2020)

    Table 19. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2015-2020)

    Table 20. North America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country (2015-2020) (K MT)

    Table 21. North America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country (2015-2020)

    Table 22. North America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country (2015-2020) (US$ Million)

    Table 23. North America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country (2015-2020)

    Table 24. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales by Country (2015-2020) (K MT)

    Table 25. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country (2015-2020)

    Table 26. Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country (2015-2020) (US$ Million)

    Table 27. Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country (2015-2020)

    Table 28. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales by Region (2015-2020) (K MT)

    Table 29. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region (2015-2020)

    Table 30. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue by Region (2015-2020) (US$ Million)

    Table 31. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2015-2020)

    Table 32. Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales by Country (2015-2020) (K MT)

    Table 33. Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country (2015-2020)

    Table 34. Latin America API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country (2015-2020) (US$ Million)

    Table 35. Latin America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country (2015-2020)

    Table 36. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales by Country (2015-2020) (K MT)

    Table 37. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country (2015-2020)

    Table 38. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue by Country (2015-2020) (US$ Million)

    Table 39. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country (2015-2020)

    Table 40. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Type (2015-2020)

    Table 41. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Type (2015-2020)

    Table 42. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) by Type (2015-2020)

    Table 43. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Type (2015-2020)

    Table 44. Global API(Active Pharmaceutical Ingredient) Intermediate Price (USD/MT) by Type (2015-2020)

    Table 45. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) by Application (2015-2020)

    Table 46. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)

    Table 47. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate by Application (2015-2020)

    Table 48. Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 49. Jigs Chemical Description and Business Overview

    Table 50. Jigs Chemical API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 51. Jigs Chemical Main Product

    Table 52. Jigs Chemical Recent Development

    Table 53. Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 54. Sanofi Winthrop Industrie S.A. Corporation Information

    Table 55. Sanofi Winthrop Industrie S.A. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 56. Sanofi Winthrop Industrie S.A. Main Product

    Table 57. Sanofi Winthrop Industrie S.A. Recent Development

    Table 58. Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 59. Shandong Jiulong Fine Chemical Co., Ltd. Corporation Information

    Table 60. Shandong Jiulong Fine Chemical Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 61. Shandong Jiulong Fine Chemical Co., Ltd. Main Product

    Table 62. Shandong Jiulong Fine Chemical Co., Ltd. Recent Development

    Table 63. Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 64. Hipharma Limited Corporation Information

    Table 65. Hipharma Limited API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 66. Hipharma Limited Main Product

    Table 67. Hipharma Limited Recent Development

    Table 68. AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 69. AMPAC Fine Chemicals Corporation Information

    Table 70. AMPAC Fine Chemicals API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 71. AMPAC Fine Chemicals Main Product

    Table 72. AMPAC Fine Chemicals Recent Development

    Table 73. BASF API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 74. BASF Corporation Information

    Table 75. BASF API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 76. BASF Main Product

    Table 77. BASF Recent Development

    Table 78. Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 79. Cambrex Corporation Corporation Information

    Table 80. Cambrex Corporation API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 81. Cambrex Corporation Main Product

    Table 82. Cambrex Corporation Recent Development

    Table 83. A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 84. A R Life Sciences Pvt. Ltd. Corporation Information

    Table 85. A R Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 86. A R Life Sciences Pvt. Ltd. Main Product

    Table 87. A R Life Sciences Pvt. Ltd. Recent Development

    Table 88. Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 89. Dragon Hwa ChemPharm. Co., Ltd. Corporation Information

    Table 90. Dragon Hwa ChemPharm. Co., Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 91. Dragon Hwa ChemPharm. Co., Ltd. Main Product

    Table 92. Dragon Hwa ChemPharm. Co., Ltd. Recent Development

    Table 93. Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Corporation Information

    Table 94. Ami Life Sciences Pvt. Ltd. Corporation Information

    Table 95. Ami Life Sciences Pvt. Ltd. API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020)

    Table 96. Ami Life Sciences Pvt. Ltd. Main Product

    Table 97. Ami Life Sciences Pvt. Ltd. Recent Development

    Table 98. Sales Base and Market Concentration Rate of Raw Material

    Table 99. Key Suppliers of Raw Materials

    Table 100. API(Active Pharmaceutical Ingredient) Intermediate Distributors List

    Table 101. API(Active Pharmaceutical Ingredient) Intermediate Customers List

    Table 102. Market Key Trends

    Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)

    Table 104. Key Challenges

    Table 105. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Type (2021-2026)

    Table 106. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Type (2021-2026)

    Table 107. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) Forecast by Type (2021-2026)

    Table 108. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) Market Share Forecast by Type (2021-2026)

    Table 109. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Application (2021-2026)

    Table 110. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) Forecast by Application (2021-2026)

    Table 111. Global API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) Forecast by Region (2021-2026)

    Table 112. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share Forecast by Region (2021-2026)

    Table 113. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Forecast by Region (2021-2026) (US$ Million)

    Table 114. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share Forecast by Region (2021-2026)

    Table 115. Research Programs/Design for This Report

    Table 116. Key Data Information from Secondary Sources

    Table 117. Key Data Information from Primary Sources

List of Figures

    Figure 1. Picture of API(Active Pharmaceutical Ingredient) Intermediate

    Figure 2. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Type: 2020 VS 2026

    Figure 3. Product Picture

    Figure 4. Product Picture

    Figure 5. Global API(Active Pharmaceutical Ingredient) Intermediate Consumption Market Share by Application: 2020 VS 2026

    Figure 6. Oncology

    Figure 7. Diabetes

    Figure 8. Endocrinology

    Figure 9. Cardiovascular Disease

    Figure 10. CNS & Neurological Disorders

    Figure 11. Global API(Active Pharmaceutical Ingredient) Intermediate Market Size 2015-2026 (US$ Million)

    Figure 12. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Capacity (K MT) (2015-2026)

    Figure 13. Global API(Active Pharmaceutical Ingredient) Intermediate Market Size Market Share by Region: 2020 Versus 2026

    Figure 14. API(Active Pharmaceutical Ingredient) Intermediate Sales Share by Manufacturers in 2020

    Figure 15. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Share by Manufacturers in 2019

    Figure 16. The Global 5 and 10 Largest Players: Market Share by API(Active Pharmaceutical Ingredient) Intermediate Revenue in 2019

    Figure 17. API(Active Pharmaceutical Ingredient) Intermediate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

    Figure 18. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region (2015-2020)

    Figure 19. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region in 2019

    Figure 20. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region (2015-2020)

    Figure 21. Global API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region in 2019

    Figure 22. North America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country in 2019

    Figure 23. North America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country in 2019

    Figure 24. U.S. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 25. U.S. API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 26. Canada API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 27. Canada API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 28. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country in 2019

    Figure 29. Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country in 2019

    Figure 30. Germany API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 31. Germany API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 32. France API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 33. France API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 34. U.K. API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 35. U.K. API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 36. Italy API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 37. Italy API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 38. Russia API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 39. Russia API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 40. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Region in 2019

    Figure 41. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Region in 2019

    Figure 42. China API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 43. China API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 44. Japan API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 45. Japan API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 46. South Korea API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 47. South Korea API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 48. India API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 49. India API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 50. Australia API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 51. Australia API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 52. Taiwan API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 53. Taiwan API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 54. Indonesia API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 55. Indonesia API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 56. Thailand API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 57. Thailand API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 58. Malaysia API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 59. Malaysia API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 60. Philippines API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 61. Philippines API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 62. Vietnam API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 63. Vietnam API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 64. Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country in 2019

    Figure 65. Latin America API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country in 2019

    Figure 66. Mexico API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 67. Mexico API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 68. Brazil API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 69. Brazil API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 70. Argentina API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 71. Argentina API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 72. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Country in 2019

    Figure 73. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue Market Share by Country in 2019

    Figure 74. Turkey API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 75. Turkey API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 76. Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 77. Saudi Arabia API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 78. U.A.E API(Active Pharmaceutical Ingredient) Intermediate Sales Growth Rate (2015-2020) (K MT)

    Figure 79. U.A.E API(Active Pharmaceutical Ingredient) Intermediate Revenue Growth Rate (2015-2020) (US$ Million)

    Figure 80. Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2015-2020)

    Figure 81. Sales Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type in 2019

    Figure 82. Revenue Share of API(Active Pharmaceutical Ingredient) Intermediate by Type (2015-2020)

    Figure 83. Revenue Market Share of API(Active Pharmaceutical Ingredient) Intermediate by Type in 2019

    Figure 84. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Growth by Type (2015-2020) (K MT)

    Figure 85. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application (2015-2020)

    Figure 86. Global API(Active Pharmaceutical Ingredient) Intermediate Sales Market Share by Application in 2019

    Figure 87. Global Revenue Share of API(Active Pharmaceutical Ingredient) Intermediate by Application (2015-2020)

    Figure 88. Global Revenue Share of API(Active Pharmaceutical Ingredient) Intermediate by Application in 2020

    Figure 89. Jigs Chemical Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 90. Sanofi Winthrop Industrie S.A. Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 91. Shandong Jiulong Fine Chemical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 92. Hipharma Limited Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 93. AMPAC Fine Chemicals Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 94. BASF Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 95. Cambrex Corporation Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 96. A R Life Sciences Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 97. Dragon Hwa ChemPharm. Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 98. Ami Life Sciences Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

    Figure 99. Price Trend of Key Raw Materials

    Figure 100. Manufacturing Cost Structure of API(Active Pharmaceutical Ingredient) Intermediate

    Figure 101. Manufacturing Process Analysis of API(Active Pharmaceutical Ingredient) Intermediate

    Figure 102. API(Active Pharmaceutical Ingredient) Intermediate Industrial Chain Analysis

    Figure 103. Channels of Distribution

    Figure 104. Distributors Profiles

    Figure 105. Porter's Five Forces Analysis

    Figure 106. North America API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2021-2026)

    Figure 107. North America API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 108. Europe API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2021-2026)

    Figure 109. Europe API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 110. Latin America API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2021-2026)

    Figure 111. Latin America API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 112. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2021-2026)

    Figure 113. Middle East and Africa API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 114. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Sales (K MT) and Growth Rate Forecast (2021-2026)

    Figure 115. Asia Pacific API(Active Pharmaceutical Ingredient) Intermediate Revenue (Million US$) and Growth Rate Forecast (2021-2026)

    Figure 116. Bottom-up and Top-down Approaches for This Report

    Figure 117. Data Triangulation

    Figure 118. Key Executives Interviewed